Page last updated: 2024-09-04

3-palmitoylcatechin and Liver Diseases

3-palmitoylcatechin has been researched along with Liver Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perrissoud, D1
Dumont, JM; Maignan, MF; Perrissoud, D1

Trials

1 trial(s) available for 3-palmitoylcatechin and Liver Diseases

ArticleYear
The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.
    Progress in clinical and biological research, 1986, Volume: 213

    Topics: Animals; Benzopyrans; Catechin; Clinical Trials as Topic; Dogs; Drug Evaluation, Preclinical; Hepatitis, Viral, Human; Humans; Liver Diseases; Papio; Rabbits; Rats; Tissue Distribution

1986

Other Studies

1 other study(ies) available for 3-palmitoylcatechin and Liver Diseases

ArticleYear
Antinecrotic effect of 3-palmitoyl-(+)-catechin against liver damage induced by galactosamine or ethanol in the rat.
    Liver, 1985, Volume: 5, Issue:2

    Topics: Animals; Benzopyrans; Catechin; Chemical and Drug Induced Liver Injury; Ethanol; Galactosamine; Hypoxia; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains

1985